Inicio › Linfoma folicular › Nueva York

Ensayos clínicos de Linfoma folicular en Nueva York

30 estudios sobre Linfoma folicular buscan participantes en Nueva York.

Ciudades en Nueva York

Texto oficial del estudio (inglés)

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

Icahn School of Medicine at Mount Sinai ( Site 1325), New York

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07634471

A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma and Marginal Zone Lymphoma Not Accomplishing a Complete Response With Upfront Therapy

Icahn School of Medicine at Mount Sinai, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06510361

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Icahn School of Medicine at Mt Sinai, New York
Stony Brook University Hospital, Stony Brook

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06091254

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Stony Brook University Hospital, Stony Brook

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06149286

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

New York University (NYU) Clinical Cancer Center, New York
Weill Cornell Medicine, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Columbia University, New York
University of Rochester, Rochester

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07226843

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Northwell Health Imbert Cancer Center, Bay Shore
NYU Langone Hospital - Brooklyn, Brooklyn
Memorial Sloan Kettering Commack, Commack
y 9 más

ReclutandoFase 3

Edades de 12 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07215910

rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder

New York State Psychiatric Institute (NYSPI) / Substance Treatment and Research Service (STARS), New York

Reclutando

Edades de 22 a 65 · Todos los sexos · Actualizado el 2 nov 2026 · NCT05974202

A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

New York University Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT05765812

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

ReclutandoFase 1/2

Edades de 13 a 90 · Todos los sexos · Actualizado el 26 oct 2026 · NCT06533579

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT07029217

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

New York Medical College, Valhalla

ReclutandoFase 2

Edades de 3 a 31 · Todos los sexos · Actualizado el 23 oct 2026 · NCT02393157

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT06860594

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Research Site, Albany
Research Site, Brooklyn
Research Site, Mineola
y 4 más

ReclutandoFase 3

Edades de 18 a 130 · Todos los sexos · Actualizado el 21 oct 2026 · NCT06549595

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

NYU Langone Health, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT05303519

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Research Site, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06526793

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

University of Rochester, Rochester

ReclutandoEstudio observacional

Edades de 0 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT07154823

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Roswell Park Comprehensive Cancer Center, Buffalo
Columbia University Medical Center, New York
Weill Cornell Medical College Newyork Presbyterian Hospital, New York
y 1 más

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT05006716

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Research Site, New York
Research Site, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06542250

Epco, Zanu, Ritux for R/R FL or MZL

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06563596

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Mount Sinai Medical Center, New York

ReclutandoFase 3

Edades de 12 a 100 · Todos los sexos · Actualizado el 11 sept 2026 · NCT06784752

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Roswell Park Comprehensive Cancer Center, Buffalo
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT05826535

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities), Commack
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT05389293

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Cancer Center - Bergen, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jul 2026 · NCT07121946

Chronic CED of TPT for Recurrent Malignant Glioma

Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jun 2026 · NCT06666712

Epcoritamab and Rituximab for First-line Follicular Lymphoma

Icahn School of Medicine at Mount Sinai Hospital, New York
University of Rochester Medical Center, Rochester

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 may 2026 · NCT05783609

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

New York Medical Center, Valhalla

ReclutandoFase 1/2

Edades de 12 a 70 · Todos los sexos · Actualizado el 15 abr 2026 · NCT04491370

Study of SGR-1505 in Mature B-Cell Neoplasms

Roswell Park Comprehensive Cancer Center, Buffalo
Weill Cornell, New York
Montefiore Medical Center, The Bronx

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Optum Medical Care PC, Westbury

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 dic 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
y 2 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.